ST. LOUIS -- Scott W. Fosko, M.D., chairman of the Department of Dermatology, has been elected secretary-treasurer of the American College of Mohs Surgery for 2011 to 2012.
|Scott W. Fosko, M.D.|
The following year, Fosko, also a SLUCare dermatologist, is expected to serve as the group's vice president, and is on track to serve as president in 2014.
More than 900 physicians who have received advanced, fellowship training in Mohs surgery, pathology and reconstructive surgery are members of the American College of Mohs Surgery.
Mohs surgery is the preferred treatment for skin cancer on the face and in other sensitive areas. It is a state-of-the-art treatment for skin cancer that involves removing an entire cancerous tumor, layer by layer, while preserving the surrounding healthy tissue. Because Mohs surgery precisely targets only the skin cancer, tumors are less likely to regrow and scarring is minimized. It is often utilized for complex tumors, such as those that are recurrent, appear to be aggressive when viewed under a microscope or have spread along a nerve.
College members who perform the procedure are sub-specialty trained physicians and have completed a three-year dermatology residency and at least one additional year of fellowship training under the supervision and guidance of a Mohs College member. Fosko currently directs a two year Mohs Surgery and Cutaneous Oncology Fellowship, and has trained seven fellows.
SLUCare dermatologists perform Mohs surgery at Anheuser Busch Institute, 1755 S. Grand Blvd., and at SLUCare Des Peres' Medical Arts Pavilion II, 2315 Dougherty Ferry Road.